Slack J.M., and Tosh D. Transdifferentiation and metaplasia-switching cell types. Curr. Opin. Genet. Dev. 11 (2001) 581-586
Slack J.M. Metaplasia and transdifferentiation: from pure biology to the clinic. Nat. Rev. Mol. Cell Biol. 8 (2007) 369-378
Yuasa Y. Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat. Rev. Cancer 3 (2003) 592-600
Blanpain C., et al. Epithelial stem cells: turning over new leaves. Cell 128 (2007) 445-458
Moore K.A., and Lemischka I.R. Stem cells and their niches. Science 311 (2006) 1880-1885
Houghton J., et al. Gastric cancer originating from bone marrow-derived cells. Science 306 (2004) 1568-1571
Li H.C., et al. Stem cells and cancer: evidence for bone marrow stem cells in epithelial cancers. World J. Gastroenterol. 12 (2006) 363-371
Sarosi G., et al. Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett's esophagus. Dis. Esophagus 21 (2008) 43-50
Suh E., and Traber P.G. An intestine-specific homeobox gene regulates proliferation and differentiation. Mol. Cell. Biol. 16 (1996) 619-625
Silberg D.G., et al. Cdx1 and cdx2 expression during intestinal development. Gastroenterology 119 (2000) 961-971
Silberg D.G., et al. CDX1 protein expression in normal, metaplastic, and neoplastic human alimentary tract epithelium. Gastroenterology 113 (1997) 478-486
Almeida R., et al. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J. Pathol. 199 (2003) 36-40
Mutoh H., et al. Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice. Gut 53 (2004) 1416-1423
Silberg D.G., et al. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology 122 (2002) 689-696
Fitzgerald R.C., et al. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut 50 (2002) 451-459
Fitzgerald R.C., et al. Inflammatory gradient in Barrett's oesophagus: implications for disease complications. Gut 51 (2002) 316-322
Tselepis C., et al. Tumour necrosis factor-α in Barrett's oesophagus: a potential novel mechanism of action. Oncogene 21 (2002) 6071-6081
Kazumori H., et al. Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium. Gut 55 (2006) 16-25
Wong N.A., et al. CDX1 is an important molecular mediator of Barrett's metaplasia. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 7565-7570
Milano F., et al. Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells. Gastroenterology 132 (2007) 2412-2421
Barros R., et al. Key elements of the BMP/SMAD pathway co-localize with CDX2 in intestinal metaplasia and regulate CDX2 expression in human gastric cell lines. J. Pathol. 215 (2008) 411-420
Yang A., et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398 (1999) 714-718
Blanpain C., and Fuchs E. p63: revving up epithelial stem-cell potential. Nat. Cell Biol. 9 (2007) 731-733
Quade B.J., et al. Expression of the p53 homologue p63 in early cervical neoplasia. Gynecol. Oncol. 80 (2001) 24-29
Wang B.Y., et al. P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumours. Hum. Pathol. 33 (2002) 921-926
Roman S., et al. Downregulation of p63 upon exposure to bile salts and acid in normal and cancer esophageal cells in culture. Am. J. Physiol. Gastrointest. Liver Physiol. 293 (2007) G45-G53
Koster M.I., et al. p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev. 18 (2004) 126-131
Murata K., et al. p63 - Key molecule in the early phase of epithelial abnormality in idiopathic pulmonary fibrosis. Exp. Mol. Pathol. 83 (2007) 367-376
Lee H.O., et al. Regulation of DeltaNp63α by tumour necrosis factor-α in epithelial homeostasis. FEBS J. 274 (2007) 6511-6522
Giannini S.L., et al. Influence of the mucosal epithelium microenvironment on Langerhans cells: implications for the development of squamous intraepithelial lesions of the cervix. Int. J. Cancer 97 (2002) 654-659
Herfs M., et al. Transforming growth factor-β1-mediated slug and snail transcription factor up-regulation reduces the density of Langerhans cells in epithelial metaplasia by affecting E-cadherin expression. Am. J. Pathol. 172 (2008) 1391-1402
Wild C.P., and Hardie L.J. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions. Nat. Rev. Cancer 3 (2003) 676-684
Burghardt E., and Ostor A.G. Site and origin of squamous cervical cancer: a histomorphologic study. Obstet. Gynecol. 62 (1983) 117-127
Zhou H., et al. Malignant transformation of human bronchial epithelial cells with the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Int. J. Cancer 106 (2003) 821-826
Limburg P.J., et al. Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib. Gastroenterology 129 (2005) 863-873
Martin R.C., et al. Chemoprevention of carcinogenic progression to esophageal adenocarcinoma by the manganese superoxide dismutase supplementation. Clin. Cancer Res. 13 (2007) 5176-5182
Hussain S.P., et al. Radical causes of cancer. Nat. Rev. Cancer 3 (2003) 276-285
Tatemichi M., et al. Enhanced expression of inducible nitric oxide synthase in chronic gastritis with intestinal metaplasia. J. Clin. Gastroenterol. 27 (1998) 240-245
Forrester K., et al. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 2442-2447
Jaiswal M., et al. Human Ogg1, a protein involved in the repair of 8-oxoguanine, is inhibited by nitric oxide. Cancer Res. 61 (2001) 6388-6393
Jaiswal M., et al. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res. 60 (2000) 184-190
Kitasato A., et al. Inflammatory cytokines promote inducible nitric oxide synthase-mediated DNA damage in hamster gallbladder epithelial cells. World J. Gastroenterol. 13 (2007) 6379-6384
Jones P.A., and Baylin S.B. The epigenomics of cancer. Cell 128 (2007) 683-692
Feinberg A.P., and Tycko B. The history of cancer epigenetics. Nat. Rev. Cancer 4 (2004) 143-153
Chalitchagorn K., et al. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 23 (2004) 8841-8846
Esteller M. Epigenetics in cancer. N. Engl. J. Med. 358 (2008) 1148-1159
Ben-Porath I., et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumours. Nat. Genet. 40 (2008) 499-507
Yu J., et al. A polycomb repression signature in metastatic prostate cancer predicts cancer outcome. Cancer Res. 67 (2007) 10657-10663
Lee S.H., et al. Hypoxic silencing of tumour suppressor RUNX3 by histone modification in gastric cancer cells. Oncogene 28 (2009) 184-194
Mitani Y., et al. Histone H3 acetylation is associated with reduced p21(WAF1/CIP1) expression by gastric carcinoma. J. Pathol. 205 (2005) 65-73
Bartling T.R., and Drumm M.L. Oxidative stress causes IL8 promoter hyperacetylation in cystic fibrosis airway cell models. Am. J. Respir. Cell Mol. Biol. 40 (2009) 58-65
Moodie F.M., et al. Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-κB activation and proinflammatory cytokine release in alveolar epithelial cells. FASEB J. 18 (2004) 1897-1899
Adcock I.M., et al. Epigenetic regulation of airway inflammation. Curr. Opin. Immunol. 19 (2007) 694-700
Kang G.H., et al. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res. 61 (2001) 2847-2851
Kang G.H., et al. Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis. Lab. Invest. 83 (2003) 635-641
Eads C.A., et al. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res. 61 (2001) 3410-3418
Lamy A., et al. Aberrant methylation of the CDKN2a/p16INK4a gene promoter region in preinvasive bronchial lesions: a prospective study in high-risk patients without invasive cancer. Int. J. Cancer 100 (2002) 189-193
Valinluck V., and Sowers L.C. Inflammation-mediated cytosine damage: a mechanistic link between inflammation and the epigenetic alterations in human cancers. Cancer Res. 67 (2007) 5583-5586
Aldenborg F., et al. Metaplastic transformation of urinary bladder epithelium: effect on mast cell recruitment, distribution, and phenotype expression. Am. J. Pathol. 153 (1998) 149-157
Dvorakova K., et al. Increased expression and secretion of interleukin-6 in patients with Barrett's esophagus. Clin. Cancer Res. 10 (2004) 2020-2028
Hodge D.R., et al. Interleukin 6 supports the maintenance of p53 tumour suppressor gene promoter methylation. Cancer Res. 65 (2005) 4673-4682
Wehbe H., et al. Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression. Cancer Res. 66 (2006) 10517-10524
Meert A.P., et al. Epidermal growth factor receptor expression in pre-invasive and early invasive bronchial lesions. Eur. Respir. J. 21 (2003) 611-615
Mathur S.P., et al. Human papilloma virus (HPV)-E6/E7 and epidermal growth factor receptor (EGF-R) protein levels in cervical cancer and cervical intraepithelial neoplasia (CIN). Am. J. Reprod. Immunol. 46 (2001) 280-287
Pardoll D. Does the immune system see tumours as foreign or self?. Annu. Rev. Immunol. 21 (2003) 807-839
Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat. Rev. Cancer 5 (2005) 263-274
Sikorski M., et al. Dynamics of cervical langerhans cell counts in the course of HPV-positive CIN treatment with the use of human recombinant interferon gamma. Eur. J. Gynaecol. Oncol. 26 (2005) 294-298
Caux C., et al. Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin. Immunopathol. 22 (2000) 345-369
Woltman A.M., and van Kooten C. Functional modulation of dendritic cells to suppress adaptive immune responses. J. Leukoc. Biol. 73 (2003) 428-441
Giannini S.L., et al. Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression. Clin. Exp. Immunol. 113 (1998) 183-189
Steinbrink K., et al. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8+ T cells resulting in a failure to lyse tumour cells. Blood 93 (1999) 1634-1642
Wang B., et al. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J. Immunol. 162 (1999) 277-283
Ludewig B., et al. Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-α, but strongly enhanced by interleukin-10. Eur. J. Immunol. 25 (1995) 1943-1950
Dean R.A., et al. Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx. Blood 112 (2008) 3455-3464
McQuibban G.A., et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J. Biol. Chem. 276 (2001) 43503-43508
Herfs M., et al. High expression of PGE2 enzymatic pathways in cervical (pre)neoplastic lesions and functional consequences for antigen-presenting cells. Cancer Immunol. Immunother. 58 (2009) 603-614
Jang T.J., et al. Expression of cyclooxygenase 2, microsomal prostaglandin E synthase 1, and EP receptors is increased in rat oesophageal squamous cell dysplasia and Barrett's metaplasia induced by duodenal contents reflux. Gut 53 (2004) 27-33
Shirahama T., and Sakakura C. Overexpression of cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder. Clin. Cancer Res. 7 (2001) 558-561
Van Rees B.P., et al. Cyclooxygenase-2 expression during carcinogenesis in the human stomach. J. Pathol. 196 (2002) 171-179
Yang L., et al. Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor. J. Clin. Invest. 111 (2003) 727-735
Jiang A., et al. Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 27 (2007) 610-624
Bailey T., et al. Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation. Am. J. Pathol. 152 (1998) 135-144
Chan A.O., et al. Deregulation of E-cadherin-catenin complex in precancerous lesions of gastric adenocarcinoma. J. Gastroenterol. Hepatol. 18 (2003) 534-539
Kato Y., et al. Frequent loss of E-cadherin and/or catenins in intrabronchial lesions during carcinogenesis of the bronchial epithelium. Lung Cancer 48 (2005) 323-330
Kobayashi M., et al. A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma. J. Immunol. 160 (1998) 5869-5873
Dalgleish A.G., and O'Byrne K.J. Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer. Adv. Cancer Res. 84 (2002) 231-276
O'Byrne K.J., and Dalgleish A.G. Chronic immune activation and inflammation as the cause of malignancy. Br. J. Cancer 85 (2001) 473-483
Moons L.M., et al. Barrett's oesophagus is characterized by a predominantly humoral inflammatory response. J. Pathol. 207 (2005) 269-276
Al-Saleh W., et al. Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix. J. Pathol. 184 (1998) 283-290
Meyer F., et al. Cutting edge: cyclooxygenase-2 activation suppresses Th1 polarization in response to Helicobacter pylori. J. Immunol. 171 (2003) 3913-3917
Uemura Y., et al. 17 β-estradiol (E2) plus tumour necrosis factor-α induces a distorted maturation of human monocyte-derived dendritic cells and promotes their capacity to initiate T-helper 2 responses. Hum. Immunol. 69 (2008) 149-157
Remoue F., et al. High intraepithelial expression of estrogen and progesterone receptors in the transformation zone of the uterine cervix. Am. J. Obstet. Gynecol. 189 (2003) 1660-1665
Oka M., et al. Immunosuppression in patients with Barrett's esophagus. Surgery 112 (1992) 11-17
Marotti B., et al. Interleukin-13 mucosal production in Helicobacter pylori-related gastric diseases. Dig. Liver Dis. 40 (2008) 240-247
Ohtani N., et al. Infiltration of CD8+ T cells containing RANTES/CCL5+ cytoplasmic granules in actively inflammatory lesions of human chronic gastritis. Lab. Invest. 84 (2004) 368-375
Wilson K.T., et al. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res. 58 (1998) 2929-2934
